Importance of adenosine triphosphate in phospholipase A2-induced rabbit renal proximal tubule cell injury.
The pathogenesis of ischemic renal tubular cell injury involves a complex interaction of different processes, including membrane phospholipid alterations and depletion of high-energy phosphate stores. To assess the role of membrane phospholipid changes due to activation of phospholipases in renal tubule cell injury, suspensions enriched in rabbit renal proximal tubule segments were incubated with exogenous phospholipase A2 (PLA2). Exogenous PLA2 did not produce any significant change in various metabolic parameters reflective of cell injury in control nonhypoxic preparations despite a significant decrease in phosphatidylethanolamine (PE) and moderate increases in lysophosphatidylcholine (LPC) and lysophosphatidylethanolamine (LPE). In contrast, exogenous PLA2 treatment of hypoxic tubules resulted in a severe degree of cell injury, as demonstrated by marked declines in tubule K+ and ATP contents and significant decreases in tubule uncoupled respiratory rates, and was associated with significant phospholipid alterations, including marked declines in phosphatidylcholine (PC) and PE and significant rises in LPC, LPE, and free fatty acids (FFA). The injurious metabolic effects of exogenous PLA2 on hypoxic tubules were reversed by addition of ATP-MgCl2 to the tubules. The protective effect of ATP-MgCl2 was associated with increases in tubule PC and PE contents and declines in LPC, LPE, and FFA contents. These experiments thus indicate that an increase in exogenous PLA2 activity produces renal proximal tubule cell injury when cell ATP levels decline, at which point phospholipid resynthesis cannot keep pace with phospholipid degradation with resulting depletion of phospholipids and accumulation of lipid by-products. High-energy phosphate store depletion appears to be an important condition for exogenous PLA2 activity to induce renal tubule cell injury.
Department of Medicine, Veterans Administration Medical Center, Ann Arbor, Michigan 48105.
V D
VD
Nguyen
D A
DA
Cieslinski
H D
HD
Humes
D000255:Adenosine Triphosphate / Q000502:physiology*; D000818:Animals; D000860:Hypoxia / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology; D007511:Ischemia / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D007687:Kidney Tubules, Proximal / Q000098:blood supply / Q000378:metabolism / Q000473:pathology*; D008274:Magnesium / Q000494:pharmacology; D015636:Magnesium Chloride; D008563:Membrane Lipids / Q000378:metabolism; D010085:Oxidative Phosphorylation; D010710:Phosphates / Q000378:metabolism; D010740:Phospholipases / Q000494:pharmacology*; D010741:Phospholipases A / Q000494:pharmacology*; D054467:Phospholipases A2; D011817:Rabbits
D008563:Membrane Lipids; D010710:Phosphates; D015636:Magnesium Chloride; D000255:Adenosine Triphosphate; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; D008274:Magnesium